Submission of Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.12.2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Supha Pharmachem Ltd on 6ix
Earlier from Supha Pharmachem
- Supha Pharmachem Ltd Press Release Dec 22 2025
- Closure of Trading Window
- Supha Pharmachem Ltd Press Release Dec 15 2025
- Announcement under Regulation 30 (LODR)-Change of Company Name
- Supha Pharmachem Ltd Press Release Dec 08 2025
Later from Supha Pharmachem
- Board Meeting Intimation for Consider Un-Audited Financial Results/Statements (Standalone & Consolidated) Of The Company For The Third Quarter And Nine Months Ended December, 31, 2025
- Supha Pharmachem Ltd Press Release Feb 03 2026
- Board Meeting Intimation for Rescheduled Of Board Meeting On 25.02.2026
- Supha Pharmachem Ltd Press Release Feb 17 2026
- Intimation Of Change In Registered Office
Follow Supha Pharmachem into a list and get an email when it puts out news.
Follow Supha Pharmachem